170 related articles for article (PubMed ID: 25659771)
1. Pyridine C-region analogs of 2-(3-fluoro-4-methylsulfonylaminophenyl)propanamides as potent TRPV1 antagonists.
Ryu H; Seo S; Lee JY; Ha TH; Lee S; Jung A; Ann J; Kim SE; Yoon S; Hong M; Blumberg PM; Frank-Foltyn R; Bahrenberg G; Schiene K; Stockhausen H; Christoph T; Frormann S; Lee J
Eur J Med Chem; 2015 Mar; 93():101-8. PubMed ID: 25659771
[TBL] [Abstract][Full Text] [Related]
2. 2-(3-Fluoro-4-methylsulfonylaminophenyl)propanamides as potent TRPV1 antagonists: structure activity relationships of the 2-oxy pyridine C-region.
Thorat SA; Kang DW; Ryu H; Kim MS; Kim HS; Ann J; Ha T; Kim SE; Son K; Choi S; Blumberg PM; Frank R; Bahrenberg G; Schiene K; Christoph T; Lee J
Eur J Med Chem; 2013 Jun; 64():589-602. PubMed ID: 23685943
[TBL] [Abstract][Full Text] [Related]
3. TRPV1 antagonist with high analgesic efficacy: 2-Thio pyridine C-region analogues of 2-(3-fluoro-4-methylsulfonylaminophenyl)propanamides.
Ha TH; Ryu H; Kim SE; Kim HS; Ann J; Tran PT; Hoang VH; Son K; Cui M; Choi S; Blumberg PM; Frank R; Bahrenberg G; Schiene K; Christoph T; Frormann S; Lee J
Bioorg Med Chem; 2013 Nov; 21(21):6657-64. PubMed ID: 24035514
[TBL] [Abstract][Full Text] [Related]
4. 2-(3-fluoro-4-methylsulfonylaminophenyl)propanamides as potent transient receptor potential vanilloid 1 (TRPV1) antagonists: structure-activity relationships of 2-amino derivatives in the N-(6-trifluoromethylpyridin-3-ylmethyl) C-region.
Kim MS; Ryu H; Kang DW; Cho SH; Seo S; Park YS; Kim MY; Kwak EJ; Kim YS; Bhondwe RS; Kim HS; Park SG; Son K; Choi S; DeAndrea-Lazarus IA; Pearce LV; Blumberg PM; Frank R; Bahrenberg G; Stockhausen H; Kögel BY; Schiene K; Christoph T; Lee J
J Med Chem; 2012 Oct; 55(19):8392-408. PubMed ID: 22957803
[TBL] [Abstract][Full Text] [Related]
5. 2-Aryl substituted pyridine C-region analogues of 2-(3-fluoro-4-methylsulfonylaminophenyl)propanamides as highly potent TRPV1 antagonists.
Ryu H; Seo S; Kim MS; Kim MY; Kim HS; Ann J; Tran PT; Hoang VH; Byun J; Cui M; Son K; Sharma PK; Choi S; Blumberg PM; Frank-Foltyn R; Bahrenberg G; Koegel BY; Christoph T; Frormann S; Lee J
Bioorg Med Chem Lett; 2014 Aug; 24(16):4044-7. PubMed ID: 25011915
[TBL] [Abstract][Full Text] [Related]
6. 2-Alkyl/alkenyl substituted pyridine C-region analogues of 2-(3-fluoro-4-methylsulfonylaminophenyl)propanamides as highly potent TRPV1 antagonists.
Ryu H; Seo S; Cho SH; Kim HS; Jung A; Kang DW; Son K; Cui M; Hong SH; Sharma PK; Choi S; Blumberg PM; Frank-Foltyn R; Bahrenberg G; Stockhausen H; Schiene K; Christoph T; Frormann S; Lee J
Bioorg Med Chem Lett; 2014 Aug; 24(16):4039-43. PubMed ID: 24948568
[TBL] [Abstract][Full Text] [Related]
7. Structure activity relationships of benzyl C-region analogs of 2-(3-fluoro-4-methylsulfonamidophenyl)propanamides as potent TRPV1 antagonists.
Ann J; Jung A; Kim MY; Kim HM; Ryu H; Kim S; Kang DW; Hong S; Cui M; Choi S; Blumberg PM; Frank-Foltyn R; Bahrenberg G; Stockhausen H; Christoph T; Lee J
Bioorg Med Chem; 2015 Nov; 23(21):6844-54. PubMed ID: 26474664
[TBL] [Abstract][Full Text] [Related]
8. t-Butyl pyridine and phenyl C-region analogues of 2-(3-fluoro-4-methylsulfonylaminophenyl)propanamides as potent TRPV1 antagonists.
Lee S; Kang DW; Ryu H; Kim C; Ann J; Lee H; Kim E; Hong S; Choi S; Blumberg PM; Frank-Foltyn R; Bahrenberg G; Stockhausen H; Christoph T; Lee J
Bioorg Med Chem; 2017 Apr; 25(8):2451-2462. PubMed ID: 28314510
[TBL] [Abstract][Full Text] [Related]
9. 2-Sulfonamidopyridine C-region analogs of 2-(3-fluoro-4-methylsulfonamidophenyl)propanamides as potent TRPV1 antagonists.
Ann J; Ki Y; Yoon S; Kim MS; Lee JU; Kim C; Lee S; Jung A; Baek J; Hong S; Choi S; Pearce LV; Esch TE; Turcios NA; Lewin NE; Ogunjirin AE; Herold BK; McCall AK; Blumberg PM; Lee J
Bioorg Med Chem; 2016 Mar; 24(6):1231-40. PubMed ID: 26860926
[TBL] [Abstract][Full Text] [Related]
10. Discovery of indane propanamides as potent and selective TRPV1 antagonists.
Ahn S; Kim YS; Kim MS; Ann J; Ha H; Yoo YD; Kim YH; Blumberg PM; Frank-Foltyn R; Bahrenberg G; Stockhausen H; Christoph T; Lee J
Bioorg Med Chem Lett; 2020 Feb; 30(3):126838. PubMed ID: 31864799
[TBL] [Abstract][Full Text] [Related]
11. Discovery of 1-(1H-indazol-4-yl)-3-((1-phenyl-1H-pyrazol-5-yl)methyl) ureas as potent and thermoneutral TRPV1 antagonists.
Kang JM; Kwon SO; Ann J; Blumberg PM; Ha H; Yoo YD; Frank-Foltyn R; Lesch B; Bahrenberg G; Stockhausen H; Christoph T; Lee J
Bioorg Med Chem Lett; 2020 Dec; 30(23):127548. PubMed ID: 32931910
[TBL] [Abstract][Full Text] [Related]
12. Pyrazole C-region analogues of 2-(3-fluoro-4-methylsulfonylaminophenyl)propanamides as potent TRPV1 antagonists.
Lee S; Kim C; Ann J; Thorat SA; Kim E; Park J; Choi S; Blumberg PM; Frank-Foltyn R; Bahrenberg G; Stockhausen H; Christoph T; Lee J
Bioorg Med Chem Lett; 2017 Sep; 27(18):4383-4388. PubMed ID: 28838698
[TBL] [Abstract][Full Text] [Related]
13. Discovery of 2-(3,5-difluoro-4-methylsulfonaminophenyl)propanamides as potent TRPV1 antagonists.
Kim C; Ann J; Lee S; Sun W; Blumberg PM; Frank-Foltyn R; Bahrenberg G; Stockhausen H; Christoph T; Lee J
Bioorg Med Chem Lett; 2018 Aug; 28(14):2539-2542. PubMed ID: 29884534
[TBL] [Abstract][Full Text] [Related]
14. 2-(Halogenated Phenyl) acetamides and propanamides as potent TRPV1 antagonists.
Kang JM; Kwon SO; Ann J; Lee S; Kim C; Do N; Jeong JJ; Blumberg PM; Ha H; Vu TNL; Yoon S; Choi S; Frank-Foltyn R; Lesch B; Bahrenberg G; Stockhausen H; Christoph T; Lee J
Bioorg Med Chem Lett; 2021 Sep; 48():128266. PubMed ID: 34273488
[TBL] [Abstract][Full Text] [Related]
15. 4-Aminophenyl acetamides and propanamides as potent transient receptor potential vanilloid 1 (TRPV1) ligands.
Kim C; Ann J; Lee S; Kim E; Choi S; Blumberg PM; Frank-Foltyn R; Bahrenberg G; Stockhausen H; Christoph T; Lee J
Bioorg Med Chem; 2018 Aug; 26(15):4509-4517. PubMed ID: 30078610
[TBL] [Abstract][Full Text] [Related]
16. Discovery of N-(3-fluoro-4-methylsulfonamidomethylphenyl)urea as a potent TRPV1 antagonistic template.
Ann J; Sun W; Zhou X; Jung A; Baek J; Lee S; Kim C; Yoon S; Hong S; Choi S; Turcios NA; Herold BK; Esch TE; Lewin NE; Abramovitz A; Pearce LV; Blumberg PM; Lee J
Bioorg Med Chem Lett; 2016 Aug; 26(15):3603-7. PubMed ID: 27317643
[TBL] [Abstract][Full Text] [Related]
17. 6,6-Fused heterocyclic ureas as highly potent TRPV1 antagonists.
Sun W; Kim HS; Lee S; Jung A; Kim SE; Ann J; Yoon S; Choi S; Lee JH; Blumberg PM; Frank-Foltyn R; Bahrenberg G; Schiene K; Stockhausen H; Christoph T; Frormann S; Lee J
Bioorg Med Chem Lett; 2015 Feb; 25(4):803-6. PubMed ID: 25597011
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of Analogues of BCTC Incorporating a Pyrrolidinyl Linker and Biological Evaluation as Transient Receptor Potential Vanilloid 1 Antagonists.
Yan L; Wang J; Pan M; Qiu Q; Huang W; Qian H
Chem Biol Drug Des; 2016 Feb; 87(2):306-11. PubMed ID: 26360809
[TBL] [Abstract][Full Text] [Related]
19. Novel piperazine urea derivatives as highly potent transient receptor potential vanilloid 1 (TRPV1) antagonists.
Hu J; Gao M; Zhang Y; Wang Y; Qiao Z; Zhang W; Wang Q; Yan L; Qian H
Bioorg Chem; 2021 Oct; 115():105229. PubMed ID: 34364049
[TBL] [Abstract][Full Text] [Related]
20. Tetrahydropyridine-4-carboxamides as novel, potent transient receptor potential vanilloid 1 (TRPV1) antagonists.
Brown BS; Keddy R; Zheng GZ; Schmidt RG; Koenig JR; McDonald HA; Bianchi BR; Honore P; Jarvis MF; Surowy CS; Polakowski JS; Marsh KC; Faltynek CR; Lee CH
Bioorg Med Chem; 2008 Sep; 16(18):8516-25. PubMed ID: 18722778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
